Learn about UCSF’s response to the coronavirus outbreak, important updates on campus safety precautions, and the latest policies and guidance on our COVID-19 resource website. You can also access information from the CDC. Learn more
A product containing healthy vaginal bacteria has proved effective against recurrent bacterial vaginosis (BV), an extremely common vaginal infection that is associated with preterm birth, HIV infection and problems with in vitro fertilization.
Pregnant women are at higher risk for many infections, but the risks of COVID-19 to mother and baby are not yet clear. UCSF experts share what we know and don’t know about COVID-19’s effects on pregnancy, the possibility of in utero transmission, and advice for pregnant women.
Administering stem cell or enzyme therapy in utero may be a path to alleviating some congenital diseases that often result in losing a pregnancy, according to a new study in mice by UCSF researchers. They showed that stem cells can enter the fetal brain during prenatal development and make up for cells that fail to make an essential protein.
Pelvic examinations and cervical cancer screenings are no longer recommended for most females under age 21, but a new study has found that millions of young women are unnecessarily undergoing the tests.
Advances in medicine and public health have dramatically extended the lifespan of hearts, lungs, and other vital organs. But for women, the ovaries remain a stubborn exception. That may soon change, says fertility expert Marcelle Cedars.
The brief surveys evidence from more than 20 studies on the safety of abortion, the harms of denying women abortions when they seek them, and what happens when abortion providers are required to obtain admitting privileges.